84 related articles for article (PubMed ID: 27233453)
21. CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4.
Popik W; Alce TM
J Biol Chem; 2004 Jan; 279(1):704-12. PubMed ID: 14570906
[TBL] [Abstract][Full Text] [Related]
22. Plasma membrane signaling in HIV-1 infection.
Abbas W; Herbein G
Biochim Biophys Acta; 2014 Apr; 1838(4):1132-42. PubMed ID: 23806647
[TBL] [Abstract][Full Text] [Related]
23. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
24. Redox control on the cell surface: implications for HIV-1 entry.
Matthias LJ; Hogg PJ
Antioxid Redox Signal; 2003 Feb; 5(1):133-8. PubMed ID: 12626125
[TBL] [Abstract][Full Text] [Related]
25. Quantifying CD4/CCR5 Usage Efficiency of HIV-1 Env Using the Affinofile System.
Webb NE; Lee B
Methods Mol Biol; 2016; 1354():3-20. PubMed ID: 26714701
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity.
Matsuda K; Hattori S; Kariya R; Komizu Y; Kudo E; Goto H; Taura M; Ueoka R; Kimura S; Okada S
Biochem Biophys Res Commun; 2015 Feb; 457(3):288-94. PubMed ID: 25576356
[TBL] [Abstract][Full Text] [Related]
27. The yeast autophagy protease Atg4 is regulated by thioredoxin.
Pérez-Pérez ME; Zaffagnini M; Marchand CH; Crespo JL; Lemaire SD
Autophagy; 2014; 10(11):1953-64. PubMed ID: 25483965
[TBL] [Abstract][Full Text] [Related]
28. A protein disulfide isomerase/thioredoxin-1 complex is physically attached to exofacial membrane tumor necrosis factor receptors: overexpression in chronic lymphocytic leukemia cells.
Söderberg A; Hossain A; Rosén A
Antioxid Redox Signal; 2013 Feb; 18(4):363-75. PubMed ID: 22775451
[TBL] [Abstract][Full Text] [Related]
29. Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry.
Harada T; Tatsumi M; Takahashi H; Sata T; Kurata T; Kojima A
Microbes Infect; 2004 Apr; 6(5):421-8. PubMed ID: 15109956
[TBL] [Abstract][Full Text] [Related]
30. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
Agrawal L; Vanhorn-Ali Z; Alkhatib G
J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
[TBL] [Abstract][Full Text] [Related]
31. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
32. Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes.
Kuzmina A; Vaknin K; Gdalevsky G; Vyazmensky M; Marks RS; Taube R; Engel S
PLoS One; 2015; 10(12):e0144043. PubMed ID: 26629902
[TBL] [Abstract][Full Text] [Related]
33. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
[TBL] [Abstract][Full Text] [Related]
34. Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1.
Esser U; Speck RF; Deen KC; Atchison RE; Sweet R; Goldsmith MA
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1845-54. PubMed ID: 11118070
[TBL] [Abstract][Full Text] [Related]
35. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation.
Delaguillaumie A; Harriague J; Kohanna S; Bismuth G; Rubinstein E; Seigneuret M; Conjeaud H
J Cell Sci; 2004 Oct; 117(Pt 22):5269-82. PubMed ID: 15454569
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779.
Gharu L; Ringe R; Bhattacharya J
Virus Res; 2011 Jun; 158(1-2):216-24. PubMed ID: 21524671
[TBL] [Abstract][Full Text] [Related]
37. Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation.
Cefai D; Ferrer M; Serpente N; Idziorek T; Dautry-Varsat A; Debre P; Bismuth G
J Immunol; 1992 Jul; 149(1):285-94. PubMed ID: 1535086
[TBL] [Abstract][Full Text] [Related]
38. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
39. The relative activity of "function sparing" HIV-1 entry inhibitors on viral entry and CCR5 internalization: is allosteric functional selectivity a valuable therapeutic property?
Muniz-Medina VM; Jones S; Maglich JM; Galardi C; Hollingsworth RE; Kazmierski WM; Ferris RG; Edelstein MP; Chiswell KE; Kenakin TP
Mol Pharmacol; 2009 Mar; 75(3):490-501. PubMed ID: 19064629
[TBL] [Abstract][Full Text] [Related]
40. Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events.
Steffens CM; Hope TJ
J Virol; 2004 Sep; 78(17):9573-8. PubMed ID: 15308751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
